Hospital de Navarra

Pamplona 31008

1 studies enrolling now · 7 studies all time

What they study most

Acute Leukemia (Category), Breast Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell of the Head and Neck, Chronic Lymphocytic Leukemia, HER2 Positive Breast Cancer, Head and Neck Cancer, Leukemia, B-cell, Leukemia, Lymphocytic, Oral Mucositis, Small Lymphocytic Lymphoma

Studies at this site

• A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Recruiting now
• The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC — Completed
• Efficacy Study on the Strategy of HSV-Tk Engineering Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia — Stopped early
• Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis — Completed
• An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene — Completed
• MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients — Stopped early
• Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers — Completed